Vetter’s European Clinical Site Receives Permanent Manufacturer’s Authorization
RAVENSBURG, Germany & RANKWEIL, Austria--(BUSINESS WIRE)--Nov 9, 2023--<a ...
TAGGED : clinical trials
Edgewise Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
BOULDER, Colo.--(BUSINESS WIRE)--Nov 9, 2023--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the third quarter of 2023 and recent business highlights.“I’m thrilled with the progress we’ve made in 2023 ...
Global Graves’ Disease Drug Pipeline Research Report 2023: Comprehensive Insights About 8+ Companies and 10+ Pipeline Drugs – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 9, 2023--The <a ...
GenScript ProBio Partners With NuclixBio to Pave the Way for South Korea’s First Large-scale Production Process for “Circular RNA Therapeutics”
SEOUL, Korea--(BUSINESS WIRE)--Nov 9, 2023--GenScript ProBio, a global multimodality CDMO and NuclixBio, a company developing treatments based on circular RNA, announced on 9th Nov that they have entered into a strategic business agreement to develop the first circular RNA-based anticancer drug ...
CD19-Targeting Therapies Show Remarkable Growth, Revolutionizing Cancer Treatment with High Response Rates – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 8, 2023--The <a ...
Strata Oncology Recognized as “Diagnostics Innovation Of The Year” by BioTech Breakthrough Awards
ANN ARBOR, Mich.--(BUSINESS WIRE)--Nov 8, 2023--<a ...